Amedeo Smart

Free Medical Literature Service

 

Amedeo

Neonatology
  Free Subscription

Articles published in
Thorax
    July 2024
  1. ASHARAM K, Mitku AAA, Ramsay L, Jeena PM, et al
    Environmental exposures associated with early childhood recurrent wheezing in the mother and child in the environment birth cohort: a time-to-event study.
    Thorax. 2024 Jul 4:thorax-2023-221150. doi: 10.1136/thorax-2023-221150.
    >> Share

    April 2024
  2. GRUDZINSKA FS, Scott A
    Unravelling the neutrophil enigma: a new insight into RSV-induced bronchiolitis in infants.
    Thorax. 2024 Apr 4:thorax-2023-221130. doi: 10.1136/thorax-2023-221130.
    >> Share

    February 2024
  3. WATKINS WJ, Course CW, Cousins M, Hart K, et al
    Impact of ambient air pollution on lung function in preterm-born school-aged children.
    Thorax. 2024 Feb 15:thorax-2023-220233. doi: 10.1136/thorax-2023-220233.
    >> Share

    January 2024
  4. HOWELLS A, Riley M, Samuels M, Aurora P, et al
    Retrospective analysis of referrals for hypoxic challenge testing in children born preterm.
    Thorax. 2024 Jan 12:thorax-2023-220677. doi: 10.1136/thorax-2023-220677.
    >> Share

    December 2023
  5. LV Q, Gallardo-Estrella L, Andrinopoulou ER, Chen Y, et al
    Automatic analysis of bronchus-artery dimensions to diagnose and monitor airways disease in cystic fibrosis.
    Thorax. 2023;79:13-22.
    >> Share

  6. ROBINSON E, Sawhney S, Cortina-Borja M, David AL, et al
    Neutrophil responses to RSV infection show differences between infant and adult neutrophils.
    Thorax. 2023 Dec 2:thorax-2023-220081. doi: 10.1136/thorax-2023-220081.
    >> Share

  7. AL-ADHAMI A, Al-Aloul M, Rushton S, Thompson RD, et al
    Early experience of a new national lung allocation scheme in the UK based on clinical urgency.
    Thorax. 2023;78:1206-1214.
    >> Share

    November 2023
  8. AHN SY, Chang YS, Lee MH, Sung S, et al
    Five-year follow-up of phase II trial of stromal cells for bronchopulmonary dysplasia.
    Thorax. 2023;78:1105-1110.
    >> Share

    October 2023
  9. GRANGER E, Davies G, Keogh RH
    Emulated trial investigating effects of multiple treatments: estimating combined effects of mucoactive nebulisers in cystic fibrosis using registry data.
    Thorax. 2023;78:1011-1018.
    >> Share

    September 2023
  10. ZIVANOVIC S, Chaban B
    Increasing respiratory burden of prematurity: can we turn the tide?
    Thorax. 2023 Sep 21:thorax-2023-220606. doi: 10.1136/thorax-2023-220606.
    >> Share

    August 2023
  11. KWOK TC, Poulter C, Algarni S, Szatkowski L, et al
    Respiratory management and outcomes in high-risk preterm infants with development of a population outcome dashboard.
    Thorax. 2023 Aug 28:thorax-2023-220174. doi: 10.1136/thorax-2023-220174.
    >> Share

  12. ROWBOTHAM NJ, Smith S, Elliott ZC, Cupid B, et al
    A refresh of the top 10 research priorities in cystic fibrosis.
    Thorax. 2023;78:840-843.
    >> Share

  13. CASEY M, Gabillard-Lefort C, McElvaney OF, McElvaney OJ, et al
    Effect of elexacaftor/tezacaftor/ivacaftor on airway and systemic inflammation in cystic fibrosis.
    Thorax. 2023;78:835-839.
    >> Share

    July 2023
  14. GIE A, Davies C, Vaida F, Morrison J, et al
    Lung function tracking in children with perinatally acquired HIV following early antiretroviral therapy initiation.
    Thorax. 2023 Jul 21:thorax-2023-220197. doi: 10.1136/thorax-2023-220197.
    >> Share

    May 2023
  15. SMITH EF, Hemy NR, Hall GL, Wilson AC, et al
    Risk factors for poorer respiratory outcomes in adolescents and young adults born preterm.
    Thorax. 2023 May 19:thorax-2022-219634. doi: 10.1136/thorax-2022-219634.
    >> Share

    April 2023
  16. PERREM L, Stanojevic S, Solomon M, Grasemann H, et al
    Evaluation of clinically relevant changes in the lung clearance index in children with cystic fibrosis and healthy controls.
    Thorax. 2023;78:362-367.
    >> Share

    March 2023
  17. BASHFORD J, Flowers W, Haworth C, Ryan J, et al
    Evaluation of a novel ELISA test using synthetic mycolic acid antigens for serodiagnosis of non-tuberculous mycobacterial (NTM) infections.
    Thorax. 2023;78:309-312.
    >> Share

  18. JONES AM
    Patient registry data highlights international differences in survival in cystic fibrosis.
    Thorax. 2023;78:223-224.
    >> Share

  19. CORIATI A, Ma X, Sykes J, Stanojevic S, et al
    Beyond borders: cystic fibrosis survival between Australia, Canada, France and New Zealand.
    Thorax. 2023;78:242-248.
    >> Share

    February 2023
  20. LI Y, Seidl E, Knoflach K, Gothe F, et al
    ABCA3-related interstitial lung disease beyond infancy.
    Thorax. 2023 Feb 20:thorax-2022-219434. doi: 10.1136/thorax-2022-219434.
    >> Share

  21. SVEDBERG M, Imberg H, Gustafsson PM, Tiddens H, et al
    Longitudinal lung clearance index and association with structural lung damage in children with cystic fibrosis.
    Thorax. 2023;78:176-182.
    >> Share

  22. COUSINS M, Hart K, Kotecha SJ, Henderson AJ, et al
    Characterising airway obstructive, dysanaptic and PRISm phenotypes of prematurity-associated lung disease.
    Thorax. 2023 Feb 1:thoraxjnl-2022-219301. doi: 10.1136/thorax-2022-219301.
    >> Share

    January 2023
  23. SAYNOR ZL, Cunningham S, Morrison L, Main E, et al
    Exercise as airway clearance therapy (ExACT) in cystic fibrosis: a UK-based e-Delphi survey of patients, caregivers and health professionals.
    Thorax. 2023;78:88-91.
    >> Share

  24. KING JA, Desai A, Semple T, Nicholson AG, et al
    Case-based discussion: neonates on extracorporeal membrane oxygenation for undiagnosed recalcitrant pulmonary hypertension-management challenges.
    Thorax. 2023;78:107-109.
    >> Share

  25. COX NS, Eldridge B, Rawlings S, Dreger J, et al
    Web-based physical activity promotion in young people with CF: a randomised controlled trial.
    Thorax. 2023;78:16-23.
    >> Share

  26. RADTKE T
    Role of physical activity and airway clearance therapy in cystic fibrosis: moving forward in a rapidly changing landscape.
    Thorax. 2023;78:3-4.
    >> Share

    December 2022
  27. GIE A, Toelen J
    Chronic neonatal lung disease: time to look beyond the alveolus.
    Thorax. 2022;77:1161-1162.
    >> Share

    September 2022
  28. KEOGH RH, Cosgriff R, Andrinopoulou ER, Brownlee KG, et al
    Projecting the impact of triple CFTR modulator therapy on intravenous antibiotic requirements in cystic fibrosis using patient registry data combined with treatment effects from randomised trials.
    Thorax. 2022;77:873-881.
    >> Share

    July 2022
  29. CRUMP C, Sundquist J, Sundquist K
    Preterm or early term birth and long-term risk of asthma into midadulthood: a national cohort and cosibling study.
    Thorax. 2022 Jul 30. pii: thorax-2022-218931. doi: 10.1136/thorax-2022-218931.
    >> Share

  30. FUJIOGI M, Zhu Z, Raita Y, Ooka T, et al
    Nasopharyngeal lipidomic endotypes of infants with bronchiolitis and risk of childhood asthma: a multicentre prospective study.
    Thorax. 2022 Jul 30. pii: thorax-2022-219016. doi: 10.1136/thorax-2022-219016.
    >> Share

    June 2022
  31. THORNTON C, Somayaji R, Chu A, Parkins MD, et al
    Human papillomavirus (HPV) and cervical dysplasia in adult female cystic fibrosis (CF) lung transplant recipients.
    Thorax. 2022;77:625-627.
    >> Share

  32. NICHOLS DP, Singh PK, Baines A, Caverly LJ, et al
    Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fibrosis: a randomised, controlled clinical trial.
    Thorax. 2022;77:581-588.
    >> Share

    May 2022
  33. HEYDARIAN M, Oak P, Zhang X, Kamgari N, et al
    Relationship between impaired BMP signalling and clinical risk factors at early-stage vascular injury in the preterm infant.
    Thorax. 2022 May 17. pii: thoraxjnl-2021-218083.
    >> Share

  34. SCHULTZ A
    Adherence to CF treatment can be improved with the right approach!
    Thorax. 2022;77:428.
    >> Share

  35. WILDMAN MJ, O'Cathain A, Maguire C, Arden MA, et al
    Self-management intervention to reduce pulmonary exacerbations by supporting treatment adherence in adults with cystic fibrosis: a randomised controlled trial.
    Thorax. 2022;77:461-469.
    >> Share

    April 2022
  36. DOYLE LW, Ranganathan S, Cheong J
    Bronchopulmonary dysplasia and expiratory airflow at 8 years in children born extremely preterm in the post-surfactant era.
    Thorax. 2022 Apr 22. pii: thoraxjnl-2022-218792.
    >> Share

  37. BARDSEN T, Roksund OD, Benestad MR, Hufthammer KO, et al
    Tracking of lung function from 10 to 35 years after being born extremely preterm or with extremely low birth weight.
    Thorax. 2022 Apr 11. pii: thoraxjnl-2021-218400.
    >> Share

  38. LENNEY W, Marlow N
    Extreme prematurity and adult respiratory disease.
    Thorax. 2022 Apr 11. pii: thoraxjnl-2021-218599.
    >> Share

  39. HORSLEY AR, Belcher J, Bayfield K, Bianco B, et al
    Longitudinal assessment of lung clearance index to monitor disease progression in children and adults with cystic fibrosis.
    Thorax. 2022;77:357-363.
    >> Share

    March 2022

  40. Correction: Association of asthma severity and educational attainment at age 6-7 years in a birth cohort: population-based record-linkage study.
    Thorax. 2022;77:e2.
    >> Share

  41. HERBERT S, Rowbotham NJ, Smith S, Wilson P, et al
    Exploring the challenges of accessing medication for patients with cystic fibrosis.
    Thorax. 2022;77:295-297.
    >> Share

    February 2022
  42. PERREM LM, McNally P, Ratjen F
    Apples to apples? Comparative analyses of national CF registries.
    Thorax. 2022;77:112-113.
    >> Share

  43. SCHLUTER DK, Ostrenga JS, Carr SB, Fink AK, et al
    Lung function in children with cystic fibrosis in the USA and UK: a comparative longitudinal analysis of national registry data.
    Thorax. 2022;77:136-142.
    >> Share

    December 2021
  44. BAYFIELD KJ, Douglas TA, Rosenow T, Davies JC, et al
    Time to get serious about the detection and monitoring of early lung disease in cystic fibrosis.
    Thorax. 2021;76:1255-1265.
    >> Share

    November 2021
  45. CUYX S, Ramalho AS, Corthout N, Fieuws S, et al
    Rectal organoid morphology analysis (ROMA) as a promising diagnostic tool in cystic fibrosis.
    Thorax. 2021;76:1146-1149.
    >> Share

    October 2021
  46. TRAPPE A, Donnelly SC, McNally P, Coppinger JA, et al
    Role of extracellular vesicles in chronic lung disease.
    Thorax. 2021;76:1047-1056.
    >> Share

    August 2021
  47. YOUNG K, Sosenko I, Claure N
    Placental dysfunction and impaired fetal growth: a relationship with bronchopulmonary dysplasia and pulmonary hypertension.
    Thorax. 2021 Aug 24. pii: thoraxjnl-2021-217476.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016